Comparative efficacy and safety of infliximab and vedolizumab therapy in patients with inflammatory bowel disease: a systematic review and meta‑analysis

Question 9: Does your institution support using estimated, reformed Nowa as the data source before 2020 for calculating the spread adjustment between the alternative reference rate

The effects of oral ferrous fumarate and intravenous iron sucrose on clinical disease activity and plasma redox status were investigated in patients with inflammatory bowel

The patients trea- ted with CT-P13 in the main trial continued this treatment in the extension phase (maintenance group) whereas patients treated with originator infliximab in the

Figure 5.3 Measured time series of the pressure for HK 416 N at two different directions from the shooting direction, with and without flash suppressor, at 84 cm from the muzzle..

Combining infliximab with clinical relevant concentrations of hydrocortisone resulted in additive effects on several cytokine concentrations in plasma after a challenge with LPS..

Complementary and alternative medicine in patients with inflammatory bowel disease: The results of a population- based inception cohort (IBSEN).. Opheim R, Bernklev T, Fagermoen

Falissard, et al., The effect of enzyme replacement therapy on clinical outcomes in male patients with Fabry disease – a systematic literature review by a European panel of

Clinical outcomes and survival of patients with myeloma and lymphoma enrolled into phase I clinical trials.. The primary objectives of phase 1 trials are typically to assess the